Quantcast
Last updated on April 24, 2014 at 12:10 EDT

Latest Radiofrequency ablation Stories

2012-02-10 12:00:00

Heart specialists at Allegheny General Hospital (AGH) have joined a select group in the country offering patients who suffer from the common and potentially deadly heart rhythm disorder ventricular tachycardia (VT) a new, minimally invasive therapy called epicardial VT ablation. Pittsburgh, PA (PRWEB) February 10, 2012 Heart specialists at Allegheny General Hospital (AGH) have joined a select group in the country offering patients who suffer from the common and potentially deadly heart...

2012-01-09 07:01:00

MORRISVILLE, N.C., Jan. 9, 2012 /PRNewswire/ -- nContact, Inc., the leading innovator in epicardial ablation devices, today announced its technology will be presented by physicians in two posters at the 17th Annual International Boston Atrial Fibrillation Symposium, January 12-14 in Boston, Massachusetts. nContact will be showcasing its Numeris® Coagulation System with VisiTrax® and next generation EPi-Sense(TM) Coagulation System at its Boston AF Symposium booth #301....

2012-01-06 07:01:00

MARLBOROUGH, Mass., Jan. 6, 2012 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight(TM) Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announced that it is scheduled to present at the 30th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Tuesday, January 10, 2012 at 10:30 a.m. PT. The presentation by Stephen Sagon, CardioFocus President and CEO, will provide an overview of the company's business, clinical and commercial successes...

2011-09-13 11:20:36

Majority of cryoballoon ablation patients show no signs of a-fib year after procedure Many patients are responding to a new, minimally invasive way of treating irregular heartbeats by freezing out the bad cells. Atrial fibrillation (A-Fib) is one such heart rhythm disorder, and it's the most common arrhythmia affecting Americans. However, new research shows that 70 percent of patients with the disorder who were treated with cryoballoon ablation, the freezing technique, are free of any...

2011-09-12 16:11:00

Majority of Cryoballoon Ablation Patients Show No Signs of A-fib Year After Procedure CHICAGO, Sept. 12, 2011 /PRNewswire-USNewswire/ -- Many patients are responding to a new, minimally invasive way of treating irregular heartbeats by freezing out the bad cells. Atrial fibrillation (A-Fib) is one such heart rhythm disorder, and it's the most common arrhythmia affecting Americans. However, new research shows that 70 percent of patients with the disorder who were treated with cryoballoon...

2011-08-31 14:39:40

Rhode Island Hospital researcher authors article in Radiology The journal Radiology will publish in its September issue an article written by Damian E. Dupuy, M.D., director of tumor ablation at Rhode Island Hospital, supporting the use of ablation procedures for the treatment of lung cancer. The article, "Image-guided Thermal Ablation of Lung Malignancies," reviews the results of nearly 100 studies conducted between 1991 and 2011 that conclude that image-guided ablation for lung cancer is...

2011-07-12 15:57:00

AKRON, Ohio, July 12, 2011 /PRNewswire/ -- Many children and teens suffering from tachycardia, or rapid heart rate, have relied on medication to regulate their heart rhythms and control symptoms such as fatigue, dizziness and fainting spells. However, doctors at the Akron Children's Hospital Arrhythmia Center have made great strides in curing tachycardia with minimally invasive procedures. To view the multimedia assets associated with this release, please click:...

2011-05-11 13:45:13

The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity. The procedure was performed by Dr. Peter Guerra, Chief of Electrophysiology, and Dr. Marc Dubuc, cardiologist and specialist in electrophysiology. This was a first in Canada following the approval of the Arctic Front device by Health Canada. A...

2011-05-04 05:30:00

ST. LOUIS, May 4, 2011 /PRNewswire/ -- Stereotaxis' (Nasdaq: STXS) continued leadership in the remote treatment of a broad spectrum of complex arrhythmias will again be prominently detailed in the scientific program of the 32nd Annual Heart Rhythm Scientific Sessions in San Francisco, California. Ten podium presentations and ten posters will feature clinical data and discussions of the value of magnetic navigation in the treatment of a variety of abnormal heart rhythms. Stereotaxis will...

2011-05-03 07:30:00

NATICK, Mass., May 3, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval and first use in Europe of its Blazer(TM) Open-Irrigated Catheter, the Company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias. The product is being launched this quarter in select CE Mark countries. The Blazer...